Author:
Russell S E,Horan R M,Stefanska A M,Carey A,Leon G,Aguilera M,Statovci D,Moran T,Fallon P G,Shanahan F,Brint E K,Melgar S,Hussey S,Walsh P T
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference41 articles.
1. Hibi, T., Inoue, N., Ogata, H. & Naganuma, M. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J. Gastroenterol. 38 (Suppl 15), 36–42 (2003).
2. Ogata, H. & Hibi, T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharm. Des. 9, 1107–1113 (2003).
3. Billiet, T., Rutgeerts, P., Ferrante, M., Van Assche, G. & Vermeire, S. Targeting TNF-alpha for the treatment of inflammatory bowel disease. Expert Opin. Biol. Ther. 14, 75–101 (2014).
4. Perrier, C. & Rutgeerts, P. New drug therapies on the horizon for IBD. Dig. Dis. 30 (Suppl 1), 100–105 (2012).
5. Khor, B., Gardet, A. & Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011).
Cited by
108 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献